NCT02947334View on ClinicalTrials.gov

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

October 31, 2016

Primary Completion Date

May 3, 2019

Study Completion Date

May 3, 2019

Conditions
Primary Hyperlipidemia or Mixed Dyslipidemia
Interventions
BIOLOGICAL

Bococizumab

Bococizumab PFS

DRUG

Placebo

Placebo

Trial Locations (1)

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02947334 - Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects | Biotech Hunter | Biotech Hunter